Bayer

Which big pharma firms are best at digital?
Which big pharma firms are best at digital?
Pharmaforum
digital pharma
Bayer
Pfizer
Boehringer Ingelheim
Flag link:
Bayer chooses UK for its AI-focused R&D hub
Bayer chooses UK for its AI-focused R&D hub
Pharmaforum
Bayer
R&D
artificial intelligence
UK
Flag link:
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Endpoints
Bayer
Ionis Pharmaceuticals
Factor XI
anti-thrombotics
clinical trials
IONIS-FXI-LR
Flag link:
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Pharmaforum
Novartis
brolucizumab
Bayer
Eylea
wet age-related macular degeneration
FDA
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Bayer
Eli Lilly
Humalong
Humulin
diabetes
whistleblower lawsuits
Flag link:
Bayer, Boston academics form joint lab to research lung disease
Bayer, Boston academics form joint lab to research lung disease
Fierce Biotech
Bayer
Brigham and Women's
Massachusetts General Hospital
lung disease
R&D
Flag link:
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer
Flag link:
Novartis backs brolucizumab with new head-to-head Eylea trial
Novartis backs brolucizumab with new head-to-head Eylea trial
Pharmaforum
Novartis
clinical trials
brolucizumab
Eylea
Bayer
Regeneron
age-related macular degeneration
Flag link:
Here's Why Elanco Animal Health Fell 21.1% in August
Here's Why Elanco Animal Health Fell 21.1% in August
Motley Fool
Elanco Health
animal healthy
M&A
Bayer
Flag link:
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
multiple sclerosis
MS
drug pricing
Biogen
Roche
Sanofi
Novartis
Teva Pharmaceutical
Bayer
Flag link:
Companies file suit in Canada challenging new rules to lower drug prices
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
Flag link:
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Endpoints
Elanco
Bayer
M&A
animal health
Flag link:
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Reuters
Roche
Rozlytrek
Bayer
Eli Lilly
personalized medicine
Flag link:
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work
Xconomy
Bayer
Versant Ventures
cell therapy
M&A
BlueRock Therapeutics
Flag link:
Bayer, Elanco could lock up animal health merger next week: report
Bayer, Elanco could lock up animal health merger next week: report
Fierce Pharma
Bayer
Elanco
M&A
animal health
Flag link:
Bayer's Prostate Cancer Drug Earns FDA Approval
Bayer's Prostate Cancer Drug Earns FDA Approval
BioSpace
Bayer
Nubeqa
darolutamide
prostate cancer
Flag link:
Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline
Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline
Fierce Biotech
Bayer
UK
Sensyne Health
artificial intelligence
cardiovascular disease
Flag link:
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Endpoints
Bayer
Orion
prostate cancer
darolutamide
FDA
Flag link:
Roche, like Bayer, was hit in Winnti cyberattack
Roche, like Bayer, was hit in Winnti cyberattack
Fierce Pharma
Bayer
Roche
hacking
cyberattack
cybersecruity
Flag link:

Pages